Elevated platelet-monocyte complexes in patients with psoriatic arthritis

Platelets

Volumn 20, Issue 7, 2009, Pages 493-497

  Pamuk, Gülsüm Emel ^a   Nuri Pamuk, Ömer ^b   Örüm, Hüseyin ^b   Arican, Özer ^b   Turgut, Burhan ^a   Demir, Muzaffer ^a  

^a TRAKYA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b TRAKYA UNIVERSITY   (Turkey)

Author keywords

CD40L; E selectin; Inflammation; Platelet monocyte complexes; Psoriasis; Psoriatic arthritis

Indexed keywords

ADENOSINE DIPHOSPHATE; C REACTIVE PROTEIN; CD40 LIGAND; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PADGEM PROTEIN; SALAZOSULFAPYRIDINE; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROL GROUP; CONTROLLED STUDY; CORRELATIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; JOINT; MALE; MONOCYTE; NEUTROPHIL; PARAMETER; PATHOGENESIS; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; SKIN; THROMBOCYTE; THROMBOCYTE ACTIVATION;

ADULT; ARTHRITIS, PSORIATIC; ATHEROSCLEROSIS; BLOOD PLATELETS; CASE-CONTROL STUDIES; CD40 LIGAND; E-SELECTIN; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; MONOCYTES; PLATELET ACTIVATION;

EID: 70350506848     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537100903165174     Document Type: Article

References (31)

1. Mastroianni A, Minutilli E, Mussi A, Bordignon V, Trento E, D'Agosto G, et al. Cytokine profiles during infliximab monotherapy in psoriatic arthritis. Br J Dermatol 2005;153: 531-1526
2. Wong K, Gladman DD, Husted J, Long JA, Farewell VT. Mortality studies in psoriatic arthritis: Results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum 1997;40:1868-1872.
3. Gonzalez-Juanatey C, Llorca J, Miranda-Filloy JA, Amigo- Diaz E, Testa A, Garcia-Porrua C, et al. Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 2007;57:287-293. (Pubitemid 47164092)
4. Kimhi O, Caspi D, Bornstein NM, Maharshak N, Gur A, Arbel Y, Comaneshter D, et al. Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum 2007;36:203-209.
5. Eder L, Zisman D, Barzilai M, Laor A, Rahat M, Rozenbaum M, et al. Subclinical atherosclerosis in psoriatic arthritis: A case-control study. J Rheumatol 2008;35:877-882.
6. Devi BS, van Noordin S, Krauzs T, Davies KA. Peripheral blood lymphocytes in SLE - hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells. J Autoimmun 1998;11:471-475.
7. Berner B, Wolf G, Hummel KM, Muller GA, Reuss-Borst MA. Increased expression of CD40 ligand (CD154) on CD4+T cells as a marker of disease activity in rheumatoid arthritis. Ann Rheum Dis 2000;59:190-195.
8. Andre P. P-selectin in haemostasis. Br J Haematol 2004;126: 298-306.
9. Andre P, Hartwell D, Hrachovinova I, Saffaripour S, Wagner DD. Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci USA 2000;97:13835-13840.
10. McCabe DJ, Harrison P, Mackie IJ, Sidhu PS, Purdy G, Lawrie AS, et al. Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack. Br J Haematol 2004;125:777-787.
11. Yamazaki M, Uchiyama S, Iwata M. Measurement of platelet fibrinogen binding and P-selectin expression by flow cytometry in patients with cerebral infarction. Thromb Res 2001;104:197-205.
12. Sarma J, Laan CA, Alam S, Jha A, Fox KA, Dransfield I. Increased platelet binding to circulating monocytes in acute coronary syndromes. Circulation 2002;105:2166-2171.
13. Furman MI, Barnard MR, Krueger LA, Fox ML, Shilale EA, Lessard DM, et al. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 2001;38:1002-1006.
14. Inwald DP, McDowall A, Peters MJ, Callard RE, Klein NJ. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 2003;92: 1041-1048.
15. Wagner AH, Güldenzoph B, Lienenlüke B, Hecker M. CD154/CD40-mediated expression of CD154 in endothelial cells: Consequences for endothelial cell-monocyte interaction. Arterioscler Thromb Vasc Biol 2004;24:715-720.
16. Davis C, Fischer J, Ley K, Sarembock IJ. The role of inflammation in vascular injury and repair. J Thromb Haemost 2003;1:1699-1709.
17. Moll JM, Wright W. Psoriatic arthritis (review). Semin Arthritis Rheum 1973;3:55-78.
18. Joseph JE, Harrison P, Mackie IJ, Isenberg DA, Machin SJ. Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br J Haematol 2001;115:451-459.
19. Villmow T, Kemkes-Matthes B, Matzdorff AC. Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes. Thromb Research 2002;108:139-145.
20. Krueger LA, Barnard MR, Frelinger AL, Furman MI, Michelson AD. Immunophenotypic analysis of platelets. In: Robinson JP, Darzynkiewicz Z, Dean PN, Dresiler LG, Rabinovitch PS, Stewart CC, Tanke HJ, Wheeless MC, editors. Current protocols in cytometry. 1st ed. New York: John Wiley & Sons, Inc.; 1997. pp 1-17.
21. Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: Studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001;104:1533-1537.
22. Berrettini M, Parise P, Constantini V, Grasselli S, Nenci GG. Platelet activation in psoriasis. Thromb Haemost 1985;53: 195-197.
23. Tamagawa-Mineoka R, Katoh N, Ueda E, Masuda K, Kishimoto S. Elevated platelet activation in patients with atopic dermatitis and psoriasis: Increased plasma levels of β-thromboglobulin and platelet factor 4. Allergol Int 2008; 57:391-396.
24. Jones SM, Dixey J, Hall ND, McHugh DJ. Expression of the cutaneous lymphocyte antigen and its counter-receptor E-selectin in the skin and joints of patients with psoriatic arthritis. Br J Rheumatol 1997;36:748-757.
25. Cordiali-Fei P, Trento E, D'Agosto G, Bordignon V, Mussi A, Ardigó M, et al. Effective therapy with anti-TNF-alpha in patients with psoriatic arthritis is associated with decreased levels of metalloproteinases and angiogenic cytokines in the sera and skin lesions. Ann N Y Acad Sci 2007;1110:578-589.
26. Kruithof E, Baeten D, De Rycke L, Vandooren B, Foell D. Synovial histopathology of psoriatic arthritis, both oligo- and polyarticular, resembles spondyloarthropathy more than it does rheumatoid arthritis. Arthritis Res Ther 2005;7: R569-R580.
27. Daoussis D, Antonopoulos AP, Liossis SNC. Increased expression of CD154 (CD40L) on stimulated T-cells from patients with psoriatic arthritis. Rheumatology 2007;46: 227-231.
28. Ohta Y, Hamada Y. In situ Expression of CD40 and CD40 ligand in psoriasis. Dermatology. 2004;209:21-28.
29. Inwald DP, McDowall A, Peters MJ, Callard RE, Klein NJ. CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 2003;92: 1041-1048.
30. Toubi E, Shoenfeld Y. The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity 2004;37:457-464.
31. Aukrust P, Damas JK, Solum NO. Soluble CD40 ligand and platelets: Self-perpetuating pathogenic loop in thrombosis and inflammation? J Am Coll Cardiol 2004;43:2326-2328.